Contact

Blog posts

 

Blog posts tagged by "Market Access"

Europe names its first device assessments

22 September 2026

Europe has named the first two medical devices selected for Joint Clinical Assessment under the EU HTA Regulation, with two further devices already in the pipeline.

> Read More

Why we usually advise against an EU Joint Scientific Consultation for medical device and diagnostic companies

26 September 2026

Understanding the relevant PICO across European markets, and the study design needed to satisfy it, matters more than ever. Yet we rarely recommend that a company apply for an EU Joint Scientific Consultation (JSC). Here is the thinking behind that.

> Read More

Neurology & Pain

29 September 2026

Chronic pain and neurological recovery are on Spain's 2026 assessment agenda.

> Read More

Devices, Imaging & Surgery

22 September 2026

From hybrid operating rooms to portable diagnostics, Spain is assessing the next wave of medical devices.

> Read More

Rehabilitation, Telemedicine & Chronic Care

15 September 2026

Care is moving into the home, and Spain's HTA system is assessing the tools that take it there.

> Read More

Neonatal, Prenatal & Metabolic Screening

08 September 2026

Early detection saves lives, and Spain's 2026 HTA agenda reflects it.

> Read More

Infection & Antimicrobial Resistance

01 September 2026

Spain is putting infection and antimicrobial resistance under the HTA microscope in 2026.

> Read More

RedETS exists

25 August 2026

Spain's 2026 health-tech assessment agenda is live, and 43 technologies are on it.

> Read More